CN102174450A - 一种抗幽门螺杆菌感染的植物乳杆菌及其用途 - Google Patents
一种抗幽门螺杆菌感染的植物乳杆菌及其用途 Download PDFInfo
- Publication number
- CN102174450A CN102174450A CN2011100598276A CN201110059827A CN102174450A CN 102174450 A CN102174450 A CN 102174450A CN 2011100598276 A CN2011100598276 A CN 2011100598276A CN 201110059827 A CN201110059827 A CN 201110059827A CN 102174450 A CN102174450 A CN 102174450A
- Authority
- CN
- China
- Prior art keywords
- plant lactobacillus
- helicobacter pylori
- pylori
- lactobacillus
- purposes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 240000006024 Lactobacillus plantarum Species 0.000 title claims description 10
- 206010019375 Helicobacter infections Diseases 0.000 title claims description 8
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims description 5
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims description 5
- 241000186660 Lactobacillus Species 0.000 claims abstract description 93
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 93
- 229940037467 helicobacter pylori Drugs 0.000 claims abstract description 33
- 230000000694 effects Effects 0.000 claims abstract description 32
- 241000590002 Helicobacter pylori Species 0.000 claims abstract description 27
- 108010046334 Urease Proteins 0.000 claims abstract description 24
- 230000002496 gastric effect Effects 0.000 claims abstract description 14
- 210000002919 epithelial cell Anatomy 0.000 claims abstract description 11
- 241000196324 Embryophyta Species 0.000 claims description 90
- 241000894006 Bacteria Species 0.000 claims description 72
- 239000007788 liquid Substances 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 22
- 239000007858 starting material Substances 0.000 claims description 10
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 9
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 9
- 235000012055 fruits and vegetables Nutrition 0.000 claims description 8
- 244000005700 microbiome Species 0.000 claims description 8
- 238000000855 fermentation Methods 0.000 claims description 7
- 230000004151 fermentation Effects 0.000 claims description 7
- 235000013406 prebiotics Nutrition 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 235000013365 dairy product Nutrition 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 5
- 230000000996 additive effect Effects 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 241000589989 Helicobacter Species 0.000 claims description 4
- 210000001187 pylorus Anatomy 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 241001473947 Helicobacter pylori SS1 Species 0.000 abstract description 28
- 239000002253 acid Substances 0.000 abstract description 12
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 241000699670 Mus sp. Species 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 24
- 239000006228 supernatant Substances 0.000 description 21
- 239000002953 phosphate buffered saline Substances 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 230000002265 prevention Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 230000000452 restraining effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000003937 drug carrier Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000001408 fungistatic effect Effects 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000003385 bacteriostatic effect Effects 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 235000013322 soy milk Nutrition 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 230000001464 adherent effect Effects 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 230000031700 light absorption Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 239000006041 probiotic Substances 0.000 description 4
- 235000018291 probiotics Nutrition 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000008485 antagonism Effects 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 3
- 230000000529 probiotic effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- -1 absorption carrier Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000015140 cultured milk Nutrition 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 235000020124 milk-based beverage Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 229940126409 proton pump inhibitor Drugs 0.000 description 2
- 239000000612 proton pump inhibitor Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001674329 Helicobacter pylori 26695 Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 238000002768 Kirby-Bauer method Methods 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 241000186866 Lactobacillus thermophilus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000026487 Triploidy Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 235000012204 lemonade/lime carbonate Nutrition 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000021108 sauerkraut Nutrition 0.000 description 1
- 239000004460 silage Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000008234 soft water Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 235000013528 soy cheese Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 238000009923 sugaring Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 108010046845 tryptones Proteins 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110059827A CN102174450B (zh) | 2011-03-11 | 2011-03-11 | 一种抗幽门螺杆菌感染的植物乳杆菌及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110059827A CN102174450B (zh) | 2011-03-11 | 2011-03-11 | 一种抗幽门螺杆菌感染的植物乳杆菌及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102174450A true CN102174450A (zh) | 2011-09-07 |
CN102174450B CN102174450B (zh) | 2012-10-03 |
Family
ID=44517708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110059827A Active CN102174450B (zh) | 2011-03-11 | 2011-03-11 | 一种抗幽门螺杆菌感染的植物乳杆菌及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102174450B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102453681A (zh) * | 2011-12-15 | 2012-05-16 | 北京大北农科技集团股份有限公司 | 用于约氏乳杆菌真空冷冻干燥的保护剂及其应用 |
CN102533618A (zh) * | 2012-02-28 | 2012-07-04 | 江南大学 | 一种植物乳杆菌ccfm8724及其用途 |
CN109609420A (zh) * | 2019-01-31 | 2019-04-12 | 山东环亿生物科技有限公司 | 一种抗幽门螺旋杆菌的益生菌组合物及其制备方法 |
CN111034891A (zh) * | 2019-12-30 | 2020-04-21 | 杭州海王生物工程有限公司 | 一种含益生菌组合物的固体饮料及其制备方法 |
CN111548972A (zh) * | 2020-06-03 | 2020-08-18 | 金华银河生物科技有限公司 | 一株具有抗幽门螺旋杆菌功能的植物乳杆菌及其应用 |
CN112438998A (zh) * | 2020-11-27 | 2021-03-05 | 四川大学 | 一种防治幽门螺杆菌感染的益生菌菌剂papch及其制备方法 |
CN112940983A (zh) * | 2021-03-31 | 2021-06-11 | 盐城维康生物科技有限公司 | 一种能增加抗幽门螺杆菌效果的植物乳杆菌制剂及其制备方法 |
CN113412060A (zh) * | 2018-12-28 | 2021-09-17 | Cj第一制糖株式会社 | 用于预防或治疗幽门螺杆菌相关疾病的泡菜 |
CN113980878A (zh) * | 2021-12-29 | 2022-01-28 | 微康益生菌(苏州)股份有限公司 | 一种抗幽门螺杆菌感染的植物乳杆菌及其应用 |
CN114711430A (zh) * | 2022-03-31 | 2022-07-08 | 杭州曼士元食品科技有限公司 | 抗幽门螺杆菌食品组合物制剂 |
CN115153026A (zh) * | 2022-04-13 | 2022-10-11 | 微康益生菌(苏州)股份有限公司 | 鼠李糖乳杆菌菌株LRa05在制备抑制幽门螺杆菌和/或变异链球菌制品方面的用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1660300A (zh) * | 2004-12-21 | 2005-08-31 | 上海交大昂立股份有限公司 | 一种含有植物乳杆菌的组合物 |
WO2007073709A1 (de) * | 2005-12-22 | 2007-07-05 | Organobalance Gmbh | Neue lactobacillus stämme und deren verwendung gegen helicobacter pylori |
-
2011
- 2011-03-11 CN CN201110059827A patent/CN102174450B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1660300A (zh) * | 2004-12-21 | 2005-08-31 | 上海交大昂立股份有限公司 | 一种含有植物乳杆菌的组合物 |
WO2007073709A1 (de) * | 2005-12-22 | 2007-07-05 | Organobalance Gmbh | Neue lactobacillus stämme und deren verwendung gegen helicobacter pylori |
Non-Patent Citations (2)
Title |
---|
《中国优秀博硕士学位论文全文数据库(硕士)医药卫生科技辑》 20060115 潘素华 体外抑制幽门螺杆菌的人源乳酸杆菌的选育 E059-47 1-8 , 第1期 * |
《中国优秀博硕士学位论文全文数据库(硕士)医药卫生科技辑》 20070315 别明江 人源乳酸杆菌对幽门螺杆菌性胃炎模型的治疗研究 E064-4 1-8 , 第3期 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102453681B (zh) * | 2011-12-15 | 2014-06-18 | 北京大北农科技集团股份有限公司 | 用于约氏乳杆菌真空冷冻干燥的保护剂及其应用 |
CN102453681A (zh) * | 2011-12-15 | 2012-05-16 | 北京大北农科技集团股份有限公司 | 用于约氏乳杆菌真空冷冻干燥的保护剂及其应用 |
CN102533618A (zh) * | 2012-02-28 | 2012-07-04 | 江南大学 | 一种植物乳杆菌ccfm8724及其用途 |
CN113412060A (zh) * | 2018-12-28 | 2021-09-17 | Cj第一制糖株式会社 | 用于预防或治疗幽门螺杆菌相关疾病的泡菜 |
CN109609420A (zh) * | 2019-01-31 | 2019-04-12 | 山东环亿生物科技有限公司 | 一种抗幽门螺旋杆菌的益生菌组合物及其制备方法 |
CN111034891A (zh) * | 2019-12-30 | 2020-04-21 | 杭州海王生物工程有限公司 | 一种含益生菌组合物的固体饮料及其制备方法 |
CN111548972A (zh) * | 2020-06-03 | 2020-08-18 | 金华银河生物科技有限公司 | 一株具有抗幽门螺旋杆菌功能的植物乳杆菌及其应用 |
CN112438998A (zh) * | 2020-11-27 | 2021-03-05 | 四川大学 | 一种防治幽门螺杆菌感染的益生菌菌剂papch及其制备方法 |
CN112438998B (zh) * | 2020-11-27 | 2023-01-10 | 四川大学 | 一种防治幽门螺杆菌感染的益生菌菌剂papch及其制备方法 |
CN112940983A (zh) * | 2021-03-31 | 2021-06-11 | 盐城维康生物科技有限公司 | 一种能增加抗幽门螺杆菌效果的植物乳杆菌制剂及其制备方法 |
CN113980878A (zh) * | 2021-12-29 | 2022-01-28 | 微康益生菌(苏州)股份有限公司 | 一种抗幽门螺杆菌感染的植物乳杆菌及其应用 |
WO2023124018A1 (zh) * | 2021-12-29 | 2023-07-06 | 微康益生菌(苏州)股份有限公司 | 一种抗幽门螺杆菌感染的植物乳杆菌及其应用 |
CN114711430A (zh) * | 2022-03-31 | 2022-07-08 | 杭州曼士元食品科技有限公司 | 抗幽门螺杆菌食品组合物制剂 |
CN115153026A (zh) * | 2022-04-13 | 2022-10-11 | 微康益生菌(苏州)股份有限公司 | 鼠李糖乳杆菌菌株LRa05在制备抑制幽门螺杆菌和/或变异链球菌制品方面的用途 |
CN115153026B (zh) * | 2022-04-13 | 2024-01-26 | 微康益生菌(苏州)股份有限公司 | 鼠李糖乳杆菌菌株LRa05在制备抑制幽门螺杆菌和/或变异链球菌制品方面的用途 |
Also Published As
Publication number | Publication date |
---|---|
CN102174450B (zh) | 2012-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102174450B (zh) | 一种抗幽门螺杆菌感染的植物乳杆菌及其用途 | |
CN102533618B (zh) | 一种植物乳杆菌ccfm8724及其用途 | |
CN102586148B (zh) | 一种能够缓解铅毒性的植物乳杆菌及其用途 | |
CN105779350B (zh) | 一种抗肠炎沙门氏菌感染的植物乳杆菌及其用途 | |
CN102586155B (zh) | 一种植物乳杆菌n13及其用途 | |
CN102827796B (zh) | 一种具有排镉功能的植物乳杆菌及其用途 | |
CN103893214B (zh) | 一种全燕麦固态混菌发酵生产益生菌活菌粉剂及制备方法 | |
CN108208853A (zh) | 一种解酒护肝益生菌低聚肽复合制剂及制备方法 | |
CN109666615A (zh) | 一种益生菌组合物及其应用 | |
CN109628358A (zh) | 一种复合益生菌及其应用 | |
CN110141585A (zh) | 一种用于调节肠道菌群的复合益生菌发酵菌剂及其制备方法 | |
CN107058158A (zh) | 一种提高犬免疫力降低腹泻发病率的复合益生菌剂及其制备和应用 | |
CN106690327A (zh) | 一种混合益生菌片剂及其低温包衣制备方法 | |
CN101560523B (zh) | 基于五株益生菌混合发酵培养物的营养组合物 | |
CN109810912A (zh) | 一株植物乳杆菌lh-511及其应用 | |
CN109929779A (zh) | 一种含有生物活性肽的益生菌制剂及其制备方法和应用 | |
CN110521785A (zh) | 益生菌发酵功能性食品及其制备 | |
CN103756926B (zh) | 一种能够缓解铜毒性的植物乳杆菌及其用途 | |
CN101677595A (zh) | 动物用饲料添加剂 | |
CN105641209A (zh) | 具有提高免疫力功能的益生菌组合物及其制备方法与应用 | |
CN106472704A (zh) | 豆浆发酵生产益生菌功能性饮料与食品及其制备方法 | |
CN108004155A (zh) | 植物乳杆菌pc-26菌株及其应用 | |
CN103031263A (zh) | 一种鼠李糖乳杆菌及其培养和微胶囊方法 | |
CN109810913A (zh) | 一株鼠李糖乳杆菌asd-9及其应用 | |
CN104630099A (zh) | 一株长双歧杆菌及其在制备活性双歧杆菌发酵饮料中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20110907 Assignee: HEBEI INATURAL BIOTECHNOLOGY Co.,Ltd. Assignor: Jiangnan University Contract record no.: X2020130000003 Denomination of invention: A Lactobacillus plantarum against Helicobacter pylori infection and its application Granted publication date: 20121003 License type: Common License Record date: 20201118 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: HEBEI INATURAL BIOTECHNOLOGY CO.,LTD. Assignor: Jiangnan University Contract record no.: X2020130000003 Date of cancellation: 20231228 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20110907 Assignee: Hebei Yiran Biotechnology Co.,Ltd. Assignor: Jiangnan University Contract record no.: X2024980001659 Denomination of invention: A plant lactobacillus resistant to Helicobacter pylori infection and its use Granted publication date: 20121003 License type: Exclusive License Record date: 20240131 |